Primary and Secondary Outcomes for Patients With Elevated Risk for Developing HA-VTE
bleeding, hospital-acquired venous thromboembolism, hemoptysis, oropharyngeal bleeding
MINOR, BLEEDING, EVENTS
Abbreviation: HA-VTE, hospital-acquired venous thromboembolism.Elevated risk defined as a predicted probability of developing hospital-acquired venous thromboembolism of 2.5% or greater.After adjustment for the predicted probability of HA-VTE (eTable 7 in Modified World Health Organization bleeding scale, assessed only in patients who were randomized to the intervention group, treatment was recommended, and treatment recommendations were followed.Once patients were initiated on prophylactic anticoagulation per the research team recommendations, they were followed up via medical record review and regular discussions with the primary team to assess for bleeding. Only intervention group patients receiving anticoagulation had bleeding scores tracked and captured due to the real-time nature of the study design. Three patients developed minor bleeding: 1 developed minor oropharyngeal bleeding (World Health Organization [WHO] bleeding scale grade I), 1 developed hemoptysis (WHO bleeding scale grade II), and 1 developed bleeding from procedure sites (WHO bleeding scale grade II). All 3 patients had resolution of the bleeding upon cessation of anticoagulation. No patients developed major bleeding events during the study (WHO bleeding scale grade III or IV).